These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12556065)

  • 1. Increasing mupirocin resistance of Staphylococcus aureus in CAPD--should it continue to be used as prophylaxis?
    Conly JM; Vas S
    Perit Dial Int; 2002; 22(6):649-52. PubMed ID: 12556065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
    Al-Hwiesh AK; Abdul Rahman IS
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection.
    Annigeri R; Conly J; Vas S; Dedier H; Prakashan KP; Bargman JM; Jassal V; Oreopoulos D
    Perit Dial Int; 2001; 21(6):554-9. PubMed ID: 11783763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.
    Hurdle JG; O'Neill AJ; Mody L; Chopra I; Bradley SF
    J Antimicrob Chemother; 2005 Dec; 56(6):1166-8. PubMed ID: 16275681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients.
    Vas SI; Conly J; Bargman JM; Oreopoulos DG
    Perit Dial Int; 1999; 19(4):313-4. PubMed ID: 10507810
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of catheter related infections in patients on CAPD.
    Thodis E; Passadakis P; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2001 Oct; 24(10):671-82. PubMed ID: 11817317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mupirocin to prevent S. aureus infections.
    Farr BM
    N Engl J Med; 2002 Jun; 346(24):1905-6. PubMed ID: 12063377
    [No Abstract]   [Full Text] [Related]  

  • 11. Intranasal mupirocin to prevent postoperative infections.
    von Eiff C; Kipp F; Becker K
    N Engl J Med; 2002 Oct; 347(15):1207-8; author reply 1207-8. PubMed ID: 12374887
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
    Laupland KB; Conly JM
    Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it possible to decrease the rate of Staphylococcus aureus peritonitis?
    Piraino B
    Perit Dial Int; 1996; 16(5):446-7. PubMed ID: 8914174
    [No Abstract]   [Full Text] [Related]  

  • 14. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis.
    Tacconelli E; Carmeli Y; Aizer A; Ferreira G; Foreman MG; D'Agata EM
    Clin Infect Dis; 2003 Dec; 37(12):1629-38. PubMed ID: 14689344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of nasal carriage of Staphylococcus aureus--is it cost-effective?
    Davey P
    J Hosp Infect; 1998 Sep; 40 Suppl B():S31-7. PubMed ID: 9777531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients.
    Herwaldt LA
    J Hosp Infect; 1998 Sep; 40 Suppl B():S13-23. PubMed ID: 9777529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus nasal carriage: role in continuous ambulatory peritoneal dialysis-associated infections.
    Herwaldt LA
    Perit Dial Int; 1993; 13 Suppl 2():S301-5. PubMed ID: 8399593
    [No Abstract]   [Full Text] [Related]  

  • 18. Mupirocin prophylaxis misses by a nose.
    Chambers HF; Winston LG
    Ann Intern Med; 2004 Mar; 140(6):484-5. PubMed ID: 15023716
    [No Abstract]   [Full Text] [Related]  

  • 19. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
    Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
    J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between nasal methicillin-resistant Staphylococcus aureus carriage and infection in liver transplant recipients.
    Patel R
    Liver Transpl; 2001 Aug; 7(8):752-3. PubMed ID: 11780649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.